Buy & Sell ARK Genomic Revolution ETF (ARKG) – ARK Genomic Revolution ETF Price Today
Key Stats
- -Market Cap
- Sector/ThematicSector
- -10.02%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 14 daysTypical Hold Time
Over the past 52 weeks, ARK Genomic Revolution ETF has traded between a low of $23.09 and a high of $36.86, highlighting its annual price range. Over the past three months, ARK Genomic Revolution ETF has recorded a drawdown of -10.02%, reflecting recent price volatility. On average, investors hold ARK Genomic Revolution ETF for approximately 14 days, indicating typical investor behavior on the platform.
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Most Recent News
Brodsky & Smith investigates fiduciary duty breaches in four major merger deals.
Brodsky & Smith LLC is investigating whether the boards of AstroNova, Open Lending, Huntsman, and Standard BioTools breached their fiduciary duties in recent merger agreements. The investigations focus on whether the companies conducted fair processe...
Canada abolishes its Ombudsperson for Responsible Enterprise, sparking criticism over human rights accountability.
The Canadian government has decided to abolish the Office of the Ombudsperson for Responsible Enterprise (CORE), which was tasked with reviewing complaints about human rights and labor abuses linked to Canadian companies operating abroad. The United ...
Canadian government shuts down corporate responsibility ombudsman, sparking union backlash
The Canadian government has decided to close the Office of the Canadian Ombudsperson for Responsible Enterprise (OCRE), a move strongly condemned by the United Steelworkers union. The union argues that while OCRE lacked independence and power, abolis...